title: [Our experience in treating diabetes mellitus with the preparation Minidiab].
abstract: 55 patients with non-insulin-dependent diabetes mellitus were treated with the new oral drug Minidiab. In 58.2% of the patients the carbohydrate metabolism was influenced. No relation between the immunoreactive insulin increase and the effect of the treatment was found. An extrapancreatic action of the drug is suggested as its hypoglycemic activity.
authors.forename: A
authors.initials: A
authors.lastname: Tsanev
authors.forename: G
authors.initials: G
authors.lastname: Lazarov
authors.forename: D
authors.initials: D
authors.lastname: Manolov
authors.forename: I
authors.initials: I
authors.lastname: Daskalova
authors.forename: N
authors.initials: N
authors.lastname: Kolebinov
mesh_terms: D000328:Adult; D000368:Aged; D001786:Blood Glucose / Q000032:analysis; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D005913:Glipizide / Q000627:therapeutic use*; D006801:Humans; D007330:Insulin Antibodies / Q000032:analysis; D008297:Male; D008875:Middle Aged; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*; D013607:Tablets; D013997:Time Factors
chemical_list: D001786:Blood Glucose; D007330:Insulin Antibodies; D013453:Sulfonylurea Compounds; D013607:Tablets; D005913:Glipizide
vernacular_title: Nashiiat opit pri lechenie na zakharniia diabet s preparata Minidiab.